• April 13, 2012

    In This Issue:



    CCI: TAVR-Themed Issue Full of Original Studies, Case Reports, More

    TAVR isn't coming. It's here.

    Catheterization and Cardiovascular Interventions (CCI) is leading the way with a special TAVR/I-themed April issue compiling several original studies and case reports (including first-in-man) complemented by thought-evoking editorials by Larry S. Dean, MD, FSCAI and Richard Heuser, MD, FSCAI.

    Headlining the issue is a study by German researchers reporting success with TAVR/I in patients with low-flow, low-gradient aortic stenosis. A team led by Michael Gotzmann, MD, with the University-Hospital Bergmannsheil in Bochum, Germany performed TAVI in 167 consecutive patients with severe aortic stenosis and high operative risk between June 2008 and December 2010.

    Find Out More About This Study

    Member Login to Access this Special Issue of CCI

    Back to Top

    SAVE THE DATES: TRIP Series to Visit Chicago & Houston in 2012

    SCAI has announced it will be continuing its popular Transradial Interventional Program (TRIP) series in 2012 hosting TRIP Chicago on September 8 and TRIP Houston on December 15.

    Organized by widely-recognized radial experts Samir Pancholy, MD, FSCAI and Sunil Rao, MD, FSCAI, both programs will focus on advanced techniques and best practices, building upon the basics taught during previous TRIP programs.

    Research shows transradial access can increase patient comfort and safety, lower bleeding complications and reduce health care costs. Learn how to increase these benefits at your cath lab by not just practicing transradial interventions, but by mastering them.

    Plan on joining us for SCAI TRIP in 2012!

    Back to Top

    Pediatric SCAI Quality Improvement Toolkit to be Unveiled at PICS-AICS

    Attending PICS-AICS in Chicago this coming week?

    If so, be sure to join SCAI and your colleagues for the unveiling of the Pediatric SCAI Quality Improvement Toolkit (SCAI-QIT) on Tuesday, April 17.

    Pediatric SCAI-QIT Chair Henri Justino, MD, FSCAI will unveil this new, exciting tool for pediatric interventionalists in the Grand Ballroom Salon I/II beginning at 6:30 AM CT on Tuesday. In addition to explaining how physicians can sign up and serve as SCAI Quality Champions, Dr. Justino will provide a review of the four modules that make up the Pediatric SCAI-QIT. If you are committed to quality in your lab, this is a must-attend.

    Later in the day SCAI's CHD Council will also hold its annual meeting at PICS-AICS in the Denver/Houston Room at 1:00 PM, CT. Phillip Moore, MD, MBA will update SCAI members on the Council's progress and discuss new initiatives.

    Be Sure to Visit SCAI at Booth 212

    Be sure to stop by SCAI's booth (212) at PICS-AICS and ask any questions you might have about your membership, SCAI initiatives, and the CHD track at SCAI 2012. SCAI will also be offering attendees special on-site discounts. Additionally this is a great opportunity to introduce colleagues to SCAI and help them learn about the Society's efforts to advance pediatric interventional cardiology worldwide.

    Back to Top

    SCAI-ELM Fellow Discusses Oral Anticoagulants With Medpage Today

    During ACC 2012 in Chicago, SCAI-ELM Fellow Thomas Tu, MD, FSCAI, participated in an impromptu video interview about the new oral anticoagulants and their potential to prevent stroke as well as treat pulmonary embolism (PE) and acute coronary syndromes. Part of an ongoing series by Medpage Today, the video featured Dr. Tu and Harry Büller, MD, discussing the results of EINSTEIN-PE, which yielded favorable results for rivaroxaban in the treatment of PE.

    Reflecting on the limitations of warfarin, Dr. Tu commented, "We're in a very exciting time in the field of cardiology because of the need for blood-thinners," said Dr. Tu. "We're fortunate now to have a number of drugs at our disposal, and we're just starting to get a feel for situations where they might be used." He pointed to initial uses in lower-risk scenarios, including deep venous thrombosis, orthopedic surgery, and preventing stroke in atrial fibrillation.

    "As we get more comfortable with these drugs and they show efficacy, we're going to start seeing them used in higher-risk settings, such as PE and even acute coronary syndromes," predicted Dr. Tu.

    Watch the Video for More on the New Class of Oral Anticoagulants

    Back to Top

    All Members Encouraged to Attend SCAI's Annual Business Meeting

    SCAI is reminding members to plan to attend the Society's Annual Business Meeting, which will be conveniently held at SCAI 2012 Scientific Sessions on Friday, May 11, 12:30 PM, in Room Jamaica AB at the Mirage Hotel Las Vegas, 3400 Las Vegas Blvd. South, Las Vegas, NV 89109.

    The meeting will include the election of SCAI officers. All are welcome to attend; current SCAI Fellows and Senior Fellows (FSCAI) are eligible to vote. Members interested in additional information on the election and/or proposed amendments are welcome to send an email to info@scai.org with "SCAI 2012 Business Meeting" in the subject line.

    Back to Top

    SCAI Reaches 500 Followers; Tweet Your #SCAI2012 Experiences

    SCAI's twitter account @SCAI passed 500 followers this week.

    Let's keep the momentum going. If you have a Twitter account, be sure to follow us @SCAI. If you tweet, please be sure to mention #SCAI programs or retweet @SCAI messages.

    Need something to promote to your patients? SCAI's @SECONDSCOUNTORG twitter account is a great resource for your patients with the latest news and updates from SCAI's Patient Education Resource, www.SecondsCount.org.

    Spread the Word About #SCAI2012

    Making plans to attend SCAI 2012 next month? Let the Twitter universe know what sessions you are looking forward to and don't forget to use the hashtag #SCAI2012.

    Also, Be Sure to Like Us on Facebook

    Like SCAI's Facebook Page!

    Like SecondsCount's Facebook Page!

    Back to Top